Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares RepurchasedShort-Term Debt repayments
Ratios

Bio-Techne (TECH) Short-Term Debt repayments (2016 - 2025)

Bio-Techne has reported Short-Term Debt repayments over the past 12 years, most recently at $40.0 million for Q4 2025.

  • Quarterly results put Short-Term Debt repayments at $40.0 million for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was $144.0 million (down 2.04% YoY), and the annual figure for FY2025 was $77.0 million, down 69.92%.
  • Short-Term Debt repayments for Q4 2025 was $40.0 million at Bio-Techne, down from $46.0 million in the prior quarter.
  • Over the last five years, Short-Term Debt repayments for TECH hit a ceiling of $441.0 million in Q3 2022 and a floor of $3.1 million in Q2 2022.
  • Median Short-Term Debt repayments over the past 5 years was $54.6 million (2021), compared with a mean of $70.4 million.
  • Peak annual rise in Short-Term Debt repayments hit 762.59% in 2022, while the deepest fall reached 97.6% in 2022.
  • Bio-Techne's Short-Term Debt repayments stood at $58.1 million in 2021, then increased by 11.24% to $64.7 million in 2022, then decreased by 10.3% to $58.0 million in 2023, then plummeted by 67.24% to $19.0 million in 2024, then surged by 110.53% to $40.0 million in 2025.
  • The last three reported values for Short-Term Debt repayments were $40.0 million (Q4 2025), $46.0 million (Q3 2025), and $50.0 million (Q2 2025) per Business Quant data.